Autopsy report · NCT03749733
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1
- Sponsor
- Grünenthal GmbH
- Sponsor type
- Industry
- Conditions
- Bioequivalence
- Interventions
- Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Reference Product); Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Test Product)
- Participants
- 0
- Sites
- 1
- Countries
- Mexico
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.